{"filings":[{"id":95936,"accession_number":"0001493152-26-018458","cik":1829247,"company_name":"BullFrog AI Holdings, Inc.","ticker":"BFRG","form_type":"8-K","filed_at":"2026-04-22T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"BullFrog AI regains Nasdaq minimum stockholders' equity compliance","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq notice on April 21, 2026 confirming compliance with $2.5M minimum equity requirement.","Compliance achieved through sales under ATM and equity-line-of-credit facilities.","Subject to mandatory one-year panel monitor; any future non-compliance could lead to delisting without grace period.","CEO cites March commercial agreement with top 5 pharma as validation and cash runway extended into late 2027."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95935,"accession_number":"0001493152-26-018365","cik":1829247,"company_name":"BullFrog AI Holdings, Inc.","ticker":"BFRG","form_type":"8-K","filed_at":"2026-04-21T23:59:59+00:00","items":["5.08","9.01"],"status":"ready","headline":"BullFrog AI sets June 11, 2026 annual meeting; shareholder proposal deadline April 29","event_type":"other","confidence":"high","bullets":["Board established June 11, 2026 as date of the 2026 Annual Meeting of Stockholders.","Because meeting is over 30 days before anniversary of 2025 meeting, shareholder proposals and nominations due by April 29, 2026.","Notices must be sent to Secretary at 325 Ellington Blvd, Unit 317, Gaithersburg, MD 20878.","Proposals must also comply with Bylaws, SEC Rule 14a-19(b), and Nevada law."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95934,"accession_number":"0001493152-26-016378","cik":1829247,"company_name":"BullFrog AI Holdings, Inc.","ticker":"BFRG","form_type":"8-K","filed_at":"2026-04-13T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"BullFrog AI secures first commercial agreement with top 5 pharma; runway into late 2027","event_type":"other_material","confidence":"high","bullets":["First commercial feasibility agreement with a top 5 global pharma for bfLEAP platform in MDD (market >$8B).","Financing in late March 2026 provides runway into late 2027; stockholders' equity >$2.5M meets Nasdaq standard.","Launched bfARENAS platform in March 2026, completing end-to-end AI platform for pharma R&D.","Ongoing Lieber Institute collaboration grants access to >2,800 human brain samples for neuropsychiatric targets."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95933,"accession_number":"0001493152-26-014595","cik":1829247,"company_name":"BullFrog AI Holdings, Inc.","ticker":"BFRG","form_type":"8-K","filed_at":"2026-04-01T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"BullFrog AI raises $3.45M, now believes it meets Nasdaq equity requirement; avoids delisting","event_type":"regulatory","confidence":"high","bullets":["Raised aggregate net proceeds of at least $3.45M from ATM sales and equity line of credit facility.","Company now believes stockholders' equity exceeds $2.5M, regaining compliance with Nasdaq Listing Rule 5550(b)(1).","Previously received Nasdaq deficiency notice on Aug 21, 2025, and had requested a hearing before the Nasdaq Panel.","Hearing request had stayed any suspension or delisting action; company expects to resolve the listing deficiency."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109375,"accession_number":"0001493152-26-013684","cik":1829247,"company_name":"BullFrog AI Holdings, Inc.","ticker":"BFRG","form_type":"8-K","filed_at":"2026-03-30T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"BullFrog AI signs feasibility agreement with top-5 pharma for MDD target discovery","event_type":"other_material","confidence":"high","bullets":["Agreement with top-5 global pharma (by 2025 revenue) for bfLEAP platform to identify novel drug targets in major depressive disorder (MDD).","One-year feasibility deal with milestone payments upon delivery of deliverables; client gets exclusive three-year option on a selected final target.","MDD market valued >$8B in 2025, expected ~$11B by 2032, per Stellar Market Research.","CEO Vin Singh calls it 'strong, high-quality validation' and expects the relationship to expand across other R&D areas.","Agreement filed as exhibit; termination clauses allow 30-day notice for no-cause termination from client."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109374,"accession_number":"0001493152-26-007656","cik":1829247,"company_name":"BullFrog AI Holdings, Inc.","ticker":"BFRG","form_type":"8-K","filed_at":"2026-02-23T23:59:59+00:00","items":["3.01","9.01"],"status":"ready","headline":"BullFrog AI receives Nasdaq delisting notice for failing equity requirement; will request hearing","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified BullFrog AI on Feb 19, 2026 that it failed to meet extension terms for the $2.5M stockholders' equity requirement.","Securities are subject to delisting unless company timely requests a hearing before the Nasdaq Hearings Panel.","Company intends to request a hearing and present details of its compliance plan, seeking additional time.","Delisting could impair trading liquidity, price, and the company's ability to raise capital.","No assurance that the Panel will grant additional time or that compliance will be achieved."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109373,"accession_number":"0001493152-26-007142","cik":1829247,"company_name":"BullFrog AI Holdings, Inc.","ticker":"BFRG","form_type":"8-K","filed_at":"2026-02-17T23:59:59+00:00","items":["3.01","9.01"],"status":"ready","headline":"BullFrog AI receives Nasdaq deficiency notice for bid price below $1.00","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified BullFrog AI on Feb 10, 2026 that common stock bid closed below $1.00 for 30 consecutive business days.","Company has 180 calendar days, until August 10, 2026, to regain compliance with Minimum Bid Price Requirement.","If not cured, company may qualify for second 180-day period by meeting other Nasdaq Capital Market standards and effecting reverse stock split.","Failure to regain compliance could lead to delisting; company will monitor and assess available options.","No immediate impact on listing; shares continue trading under BFRG and BFRGW on Nasdaq Capital Market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125847,"accession_number":"0001493152-25-029636","cik":1829247,"company_name":"BullFrog AI Holdings, Inc.","ticker":"BFRG","form_type":"8-K","filed_at":"2025-12-30T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"BullFrog AI details 2025 progress, pharma partnerships, and 2026 catalysts","event_type":"other_material","confidence":"medium","bullets":["Annual cash burn ~$6.2M; $10M equity line and ATM provide financing flexibility.","Multiple advanced pharma discussions for out-licensing or discovery collaborations with upfront/milestone payments.","Sygnature Discovery collaboration expected to generate revenue through 2028; sales kickoff in Sept 2025.","Eleison data from late-stage oncology collaboration accepted for ASCO GI Cancers Symposium Jan 9, 2026.","Launched bfPREP data prep tool; reduces data prep from months to days, enabling earlier engagement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125846,"accession_number":"0001493152-25-019360","cik":1829247,"company_name":"BullFrog AI Holdings, Inc.","ticker":"BFRG","form_type":"8-K","filed_at":"2025-10-24T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"BullFrog AI stockholders approve reverse stock split and 750,000 share increase to equity plan","event_type":"other_material","confidence":"high","bullets":["Approved reverse stock split at ratio between 1:2 and 1:15, with Board discretion on final ratio.","Approved issuance of 20%+ of outstanding common stock to Lincoln Park Capital Fund under purchase agreement.","Approved amendment to 2022 equity plan increasing share reserve by 750,000 (from 900k to 1.65M pre-split).","Special Meeting held Oct 22, 2025; 56.02% of shares represented; all proposals passed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125845,"accession_number":"0001493152-25-017599","cik":1829247,"company_name":"BullFrog AI Holdings, Inc.","ticker":"BFRG","form_type":"8-K","filed_at":"2025-10-09T23:59:59+00:00","items":["3.01","9.01"],"status":"ready","headline":"BullFrog AI receives Nasdaq extension until Feb 17, 2026 to meet equity requirement","event_type":"regulatory","confidence":"high","bullets":["Nasdaq granted BullFrog AI an extension until Feb 17, 2026 to regain compliance with $2.5M minimum stockholders' equity requirement.","Company received initial deficiency notice on Aug 21, 2025 and submitted a compliance plan in late September 2025.","If equity shortfall not cured by deadline, common stock (BFRG) and warrants (BFRGW) face delisting from Nasdaq.","Company intends to take reasonable measures but cannot assure regaining compliance by the deadline."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142600,"accession_number":"0001493152-25-014653","cik":1829247,"company_name":"BullFrog AI Holdings, Inc.","ticker":"BFRG","form_type":"8-K","filed_at":"2025-09-23T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Bullfrog AI reduces stockholder quorum to 33.33% and announces 2025 annual meeting results","event_type":"other_material","confidence":"high","bullets":["Quorum for stockholder meetings reduced to 33.33% of shares outstanding, effective September 18, 2025.","Four directors elected: William Enright, Jason D. Hanson, R. Donald Elsey, Vininder Singh.","M&K CPAs ratified as independent auditor for fiscal 2025 with 5,885,223 votes for, 98,872 against.","Annual meeting had 59.50% of shares represented, totaling 5,999,172 votes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142599,"accession_number":"0001493152-25-013729","cik":1829247,"company_name":"BullFrog AI Holdings, Inc.","ticker":"BFRG","form_type":"8-K","filed_at":"2025-09-16T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"BullFrog AI secures $10M equity line with Lincoln Park Capital","event_type":"other_material","confidence":"high","bullets":["Entered purchase agreement with Lincoln Park Capital Fund for up to $10M of common stock over 36 months.","Company may sell shares at its discretion from time to time; Lincoln Park obligated to buy subject to conditions.","Issued 147,682 commitment shares to Lincoln Park as consideration for the facility.","Exchange cap of 2,048,936 shares (19.99% of outstanding) unless stockholder approval or average price condition met.","Net proceeds expected for working capital; no short selling by Lincoln Park during term."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142598,"accession_number":"0001641172-25-025710","cik":1829247,"company_name":"BullFrog AI Holdings, Inc.","ticker":"BFRG","form_type":"8-K","filed_at":"2025-08-27T23:59:59+00:00","items":["3.01","5.02"],"status":"ready","headline":"BullFrog AI receives Nasdaq deficiency letter for equity shortfall; issues 267,842 share retention awards","event_type":"other_material","confidence":"high","bullets":["Stockholders' equity of $2,188,110 as of June 30, 2025 falls below Nasdaq's $2.5M minimum requirement.","Company has 45 days to submit a compliance plan; possible 180-day extension if plan accepted.","Board granted refresh equity awards totaling 267,842 shares to executives and directors.","Awards consist of 33% immediate vesting stock and 67% RSUs vesting 50% each on Sep 1, 2026 and Sep 1, 2027.","Existing stock options are significantly underwater; awards intended for retention during critical period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160676,"accession_number":"0001641172-25-014872","cik":1829247,"company_name":"BullFrog AI Holdings, Inc.","ticker":"BFRG","form_type":"8-K","filed_at":"2025-06-12T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"BullFrog AI enters collaboration with Sygnature Discovery targeting $15M-$30M revenue through 2028","event_type":"other_material","confidence":"high","bullets":["Collaboration with UK-based CRO Sygnature Discovery to offer BullFrog Data Networks to global biopharma clients.","Expected revenue for BullFrog AI from the collaboration: $15-$30 million through 2028.","BullFrog Data Networks is powered by its bfLEAP engine, aimed at accelerating target discovery and drug development.","CEO Vin Singh calls it a major commercial milestone; Sygnature CTO Stuart Onions confirms platform complements their offerings.","No upfront or milestone payments disclosed; revenue projections are forward-looking."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160675,"accession_number":"0001641172-25-006356","cik":1829247,"company_name":"BullFrog AI Holdings, Inc.","ticker":"BFRG","form_type":"8-K","filed_at":"2025-04-28T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Bullfrog AI enters $20M at-the-market equity distribution agreement with BTIG","event_type":"other_material","confidence":"high","bullets":["Agreement with BTIG to sell up to $20M of common stock via ATM offerings at market prices.","Company pays 3% commission; no obligation to sell any shares; BTIG uses commercially reasonable efforts.","Shares offered under existing S-3 shelf (Reg. No. 333-281341) effective August 21, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":178891,"accession_number":"0001493152-25-008518","cik":1829247,"company_name":"BullFrog AI Holdings, Inc.","ticker":"BFRG","form_type":"8-K","filed_at":"2025-02-27T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Bullfrog AI enters collaboration with Eleison to optimize Phase 3 pancreatic cancer trial","event_type":"other_material","confidence":"high","bullets":["Collaboration announced Feb 27, 2025; Bullfrog AI to apply bfLEAP platform to Eleison's glufosfamide Phase 3 trial.","Bullfrog Data Networks will analyze safety signals and extract predictive biomarkers from prior and ongoing studies.","Eleison's ongoing glufosfamide Phase 3 trial targets second-line pancreatic cancer; expected completion in 2027.","Financial terms of the agreement were not disclosed.","Partnership also covers Eleison's pipeline programs ILC (lung cancer) and DBD (brain cancers)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}